Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Third Quarter Ended March 2020; Provides Earnings Guidance for the Year Ending June 30, 2020
For the year ending June 30, 2020, the company expects consolidated net sales to be JPY 1,110 million, operating loss to be JPY 56 million, loss attributable to owners of parent to be JPY 85 million and basic loss per share to be JPY 9.90.